The veterinary vaccine manufacturers industry in the US plays a crucial role in protecting animal health. Companies in this space develop and produce vaccines for various species, including pets and livestock. They aim to prevent and control infectious diseases, promoting both animal and public health. As consumer awareness of animal welfare grows, the demand for innovative vaccines is rising. The industry is increasingly focused on research and collaboration with biotech firms, leading to advanced solutions. With ongoing challenges from emerging diseases, stakeholders are prioritizing innovative approaches that enhance vaccine effectiveness and affordability, ensuring better health for animals nationwide.


The investors in this field reflect a mix of prominent venture capital firms based in major US cities like San Francisco and New York. Established between 1946 and 2023, these institutions vary in size, ranging from small firms with a few team members to large ones with thousands. In 2024, they collectively closed numerous strategic deals, supporting a range of initiatives related to veterinary vaccines. Each investor showcases unique investment strategies, aiming to enhance developments in animal health through robust funding and mentorship.


Top 15 Veterinary Vaccine Manufacturers Investors in the US


1. OrbiMed

  • Website: orbimed.com
  • Type: Venture Capital
  • Headquarters: New York, New York, United States (USA)
  • Founded year: 1989
  • Headcount: 51-200
  • Number of deals in 2024: 52
  • LinkedIn: orbimed-advisors

OrbiMed is a New York-based investment firm specializing in healthcare investments, founded in 1989. It manages approximately $17 billion in assets across various investment strategies, focusing on biopharmaceuticals, medical devices, and healthcare services. Notably, OrbiMed has participated in significant transactions within the veterinary sector, including a $33 million Series B2 financing round for Scout Bio, a company developing gene therapy for chronic diseases in pets. This investment highlights OrbiMed's commitment to advancing healthcare innovations, including those applicable to veterinary medicine. Additionally, OrbiMed has been involved in other healthcare-related investments, reinforcing its position as a key player in the healthcare investment landscape.


2. Sosv

  • Website: sosv.com
  • Type: Venture Capital
  • Headquarters: United States (USA)
  • Founded year: 1995
  • Headcount: 51-200
  • Number of deals in 2024: 170
  • LinkedIn: sosv

Sosv is a venture capital firm founded in 1995, based in the United States, that specializes in funding and supporting deep tech startups through its development programs. The firm provides venture capital investment and resources to help startups grow and succeed in various sectors, including health and climate technology. Notably, Sosv has been involved in several transactions within the veterinary space, such as multiple funding rounds for AnimalBiome, which raised funds in 2016, 2018, 2020, and 2022, focusing on animal health solutions. Additionally, they invested in Vetherapy in 2018, further demonstrating their commitment to the veterinary industry. Through these investments, Sosv connects innovative companies in the veterinary sector with the necessary resources to thrive.


3. Y Combinator

  • Website: ycombinator.com
  • Type: Venture Capital
  • Headquarters: San Francisco, California, United States (USA)
  • Founded year: 2005
  • Headcount: 51-200
  • Number of deals in 2024: 802
  • LinkedIn: y-combinator

Y Combinator is a prominent startup accelerator and venture capital firm based in San Francisco, California, founded in 2005. It provides funding and mentorship to early-stage technology companies, helping entrepreneurs launch and grow their businesses through structured programs and resources like the Startup School. Y Combinator has successfully launched over 4,000 startups, establishing itself as a key player in the technology startup ecosystem. Notably, Y Combinator has invested in companies relevant to the veterinary sector, such as One Health Company, which raised $10 million to expand its veterinary product FidoCure, and Furmacy, which focuses on veterinary health solutions. These investments highlight Y Combinator's engagement in the veterinary vaccine and health industry, showcasing its diverse investment portfolio that includes significant players in the veterinary space.


4. Perceptive Advisors


Perceptive Advisors is a New York-based venture capital firm founded in 1999, specializing in the life sciences sector. The firm provides capital solutions and investment management services to both private and public healthcare companies, with a strong focus on biotechnology, pharmaceuticals, and medical devices. Notably, Perceptive Advisors has been involved in significant transactions within the vaccine development space, such as their investment in VBI Vaccines, where they participated in multiple funding rounds totaling over $45 million. This includes a $23.6 million financing round in December 2016, where they acquired a 15.8% stake in the company. Additionally, they participated in a $135 million crossover financing round for HilleVax, which is developing a vaccine candidate for norovirus. These transactions highlight their commitment to supporting innovative healthcare solutions, including those relevant to vaccine development, which is pertinent to the veterinary vaccine sector.


5. Frazier Healthcare Partners


Frazier Healthcare Partners is a venture capital firm based in Seattle, Washington, specializing in healthcare and life sciences investments. Founded in 1991, the firm focuses on growth buyout investments in profitable healthcare businesses and innovative biopharmaceuticals. They have a strong track record of supporting companies that advance medical technologies and therapies. Notably, Frazier has participated in funding rounds for Scout Bio, which is developing gene therapy technologies for chronic diseases in pets, highlighting their engagement in the veterinary sector. Their investment strategy includes backing companies that are pioneering advancements in health, which may extend to veterinary vaccines and related innovations.


6. Deep Tech Fund (an Alumni Ventures Fund)

  • Website: av.vc
  • Type: Venture Capital
  • Headquarters: Manchester, New Hampshire, United States (USA)
  • Founded year: 2023
  • Headcount: 51-200
  • Number of deals in 2024: 258
  • LinkedIn: deep-tech-fund-av-focused-fund

Deep Tech Fund (an Alumni Ventures Fund) is a venture capital firm founded in 2023, based in Manchester, New Hampshire, USA. The firm provides accredited investors and institutions with access to professionally-managed, diversified venture portfolios, leveraging a network of over 10,000 investors. The fund has been active in various sectors, including veterinary health, as evidenced by its investments in companies like Gallant Pet, which focuses on pet health solutions, and Koala Health, which raised $20 million for its veterinary-related initiatives. These transactions highlight the fund's engagement in the veterinary sector, making it a relevant player in the veterinary vaccine manufacturers context.


7. IndieBio

  • Website: indiebio.co
  • Type: Venture Capital
  • Headquarters: San Francisco, California, United States (USA)
  • Founded year: 2015
  • Headcount: 1-10
  • Number of deals in 2024: 76
  • LinkedIn: indiebio

IndieBio is a venture capital firm founded in 2015, based in San Francisco, California, specializing in biotechnology. The firm provides investment, mentorship, and networking opportunities to biotech entrepreneurs, helping them develop innovative solutions across various sectors, including climate and food. Notably, IndieBio has invested in companies like AnimalBiome, which focuses on gut health solutions for pets, and Vetherapy, which is involved in veterinary therapeutics. These investments highlight IndieBio's engagement in the veterinary space, particularly in areas that could intersect with vaccine development and animal health. In 2024, IndieBio continued to support emerging biotech firms, including Calder Biosciences, which may also have applications in veterinary medicine.


8. Janus Henderson Investors

  • Website: janushenderson.com
  • Type: Private Equity
  • Headquarters: Denver, Colorado, United States (USA)
  • Founded year: 2017
  • Headcount: 1001-5000
  • Number of deals in 2024: 39
  • LinkedIn: janus-henderson-emea

Janus Henderson Investors is a private equity firm based in Denver, Colorado, founded in 2017. The firm specializes in asset management, offering a diverse range of investment products including ETFs, mutual funds, and managed accounts. With a global operational footprint and a focus on disciplined investment strategies, Janus Henderson serves individual investors, financial professionals, and institutional clients. Notably, they have participated in several significant funding rounds in the biotechnology sector, including investments in Curevo, a clinical-stage biotechnology company focused on vaccine development, and SutroVax, which is advancing broad-spectrum pneumococcal vaccine candidates. These transactions highlight Janus Henderson's engagement in the vaccine development space, which could be relevant to veterinary vaccine manufacturers as well.


9. Polaris Partners

  • Website: polarispartners.com
  • Type: Venture Capital
  • Headquarters: Boston, Massachusetts, United States (USA)
  • Founded year: 1996
  • Headcount: 11-50
  • Number of deals in 2024: 19
  • LinkedIn: polaris-partners

Polaris Partners is a venture capital firm founded in 1996, based in Boston, Massachusetts, specializing in healthcare and biotechnology investments. The firm partners with entrepreneurs to provide funding and strategic guidance, helping them innovate and grow their businesses. Their portfolio includes a diverse range of companies focused on transformative healthcare solutions. Notably, Polaris has invested in Covetrus, which raised funds in a seed round in 2021 and is a key player in the veterinary market, providing technology and services to veterinarians. Additionally, they have invested in One Health Company, which raised $10 million to expand its veterinary health product, FidoCure®. These transactions highlight Polaris Partners' active engagement in the veterinary sector, particularly in companies that may contribute to veterinary vaccine development and distribution.


10. F-Prime


F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts, founded in 1946. The firm specializes in creating and investing in healthcare and technology companies, providing both venture capital investments and advisory services to entrepreneurs. F-Prime has a global presence and a strong focus on innovative solutions in the healthcare sector. Notably, they have participated in significant transactions within the veterinary field, such as leading a $60.5 million Series B financing round for Invetx, a company developing monoclonal antibodies for dogs and cats. They also played a key role in the funding of Embark Veterinary, which aims to improve canine health and longevity. These transactions highlight F-Prime's commitment to advancing veterinary healthcare, particularly in the development of therapeutics and health solutions for animals.


11. GV (Google Ventures)

  • Website: gv.com
  • Type: Venture Capital
  • Headquarters: San Francisco Bay Area, California, United States (USA)
  • Founded year: 2009
  • Headcount: 51-200
  • Number of deals in 2024: 74
  • LinkedIn: gv

GV (Google Ventures) is a venture capital firm founded in 2009, based in the San Francisco Bay Area, with over $10 billion in assets under management. The firm focuses on various sectors, including life sciences and artificial intelligence, and partners with innovative technology startups. Notably, GV has invested in Invetx, which raised $60.5 million to advance its monoclonal antibody pipeline for chronic and serious diseases in dogs and cats, highlighting their commitment to veterinary medicine. Additionally, GV participated in funding rounds for SpyBiotech, a company developing a novel vaccine technology platform, indicating their interest in vaccine development that could have applications in both human and veterinary medicine. These transactions demonstrate GV's active role in supporting advancements in veterinary therapeutics and vaccines.


12. Venrock

  • Website: venrock.com
  • Type: Venture Capital
  • Headquarters: Palo Alto, California, United States (USA)
  • Founded year: 1969
  • Headcount: 51-200
  • Number of deals in 2024: 11
  • LinkedIn: venrock

Venrock is a venture capital firm founded in 1969, based in Palo Alto, California. The firm has a strong focus on healthcare and technology investments. Notably, Venrock was involved in the seed round for IDEXX Laboratories, a leading company in veterinary diagnostics and vaccines, which highlights their engagement in the veterinary sector. Additionally, Venrock has participated in various funding rounds for companies like Acceleron Pharma, which, while primarily focused on human health, showcases their broader interest in the life sciences. Their investment strategy includes supporting innovative companies that improve health outcomes, which aligns with the goals of veterinary vaccine manufacturers.


13. Casdin Capital, LLC

  • Website: casdincapital.com
  • Type: Venture Capital
  • Headquarters: New York, New York, United States (USA)
  • Founded year: 2012
  • Headcount: 11-50
  • Number of deals in 2024: 9
  • LinkedIn: casdin-capital-llc

Casdin Capital, LLC is a venture capital firm based in New York, specializing in the life sciences sector. Founded in 2012, the firm focuses on investing in healthcare, biotechnology, synthetic biology, and technology, providing funding and strategic partnerships to innovative companies. Notably, Casdin Capital has participated in significant transactions within the veterinary space, including their investment in Invetx, which raised $60.5 million in a Series B financing round aimed at advancing monoclonal antibody therapies for dogs and cats. This involvement highlights their commitment to supporting advancements in veterinary health. Additionally, their broader investment strategy includes companies like Gritstone bio and Orbital Therapeutics, which, while primarily focused on human health, showcases their expertise in biotechnology and potential applications in various health sectors.


14. Michelson Impact Ventures

  • Website: michelson.vc
  • Type: Corporate
  • Headquarters: Los Angeles, California, United States (USA)
  • Founded year: 2016
  • Headcount: 1-10
  • Number of deals in 2024: 1
  • LinkedIn: michelson-impact-ventures

Michelson Impact Ventures is a social change fund based in Los Angeles, California, founded in 2016. The firm deploys impact investment capital into mission-aligned start-ups across various sectors, including education and healthcare. They support innovations through funding and accelerator programs, aiming to drive social change and improve outcomes for underserved communities. Notably, they have invested in several companies relevant to the veterinary sector, including VetVerifi, which raised $1,500,000 in a Pre-Seed round in March 2024. Other investments include AnimalBiome and Mixlab, which, while not directly focused on vaccines, indicate a broader interest in animal health and wellness. Their diverse portfolio reflects a commitment to supporting innovations that can lead to positive social impact, including in the veterinary field.


15. Morningside


Morningside is a venture capital firm based in Newton, Massachusetts, founded in 1986. The firm specializes in making investments across various sectors, particularly in biotech and digital health. Morningside partners with startups and management teams to develop innovative solutions in healthcare, addressing the need for funding and support in these industries. Notably, Morningside has been involved in significant transactions such as the $30 million Series A investment in Meissa Vaccines, which is advancing its RSV vaccine into clinical trials. This investment highlights Morningside's engagement in the vaccine development space, showcasing their interest in supporting companies that are working on vaccine technologies. Additionally, Morningside has participated in other biotech investments, indicating a broad interest in health-related innovations.



Veterinary Vaccine Manufacturers Insights: Key Investors in the US


InvestorHeadquarterSizeFoundedDeals 2024
OrbiMedNew York, New York, United States (USA)51-200198952
SosvUnited States (USA)51-2001995170
Y CombinatorSan Francisco, California, United States (USA)51-2002005802
Perceptive AdvisorsNew York, New York, United States (USA)11-50199945
Frazier Healthcare PartnersSeattle, Washington, United States (USA)51-200199127
Deep Tech Fund (an Alumni Ventures Fund)Manchester, New Hampshire, United States (USA)51-2002023258
IndieBioSan Francisco, California, United States (USA)1-10201576
Janus Henderson InvestorsDenver, Colorado, United States (USA)1001-5000201739
Polaris PartnersBoston, Massachusetts, United States (USA)11-50199619
F-PrimeCambridge, Massachusetts, United States (USA)11-50194639
GV (Google Ventures)San Francisco Bay Area, California, United States (USA)51-200200974
VenrockPalo Alto, California, United States (USA)51-200196911
Casdin Capital, LLCNew York, New York, United States (USA)11-5020129
Michelson Impact VenturesLos Angeles, California, United States (USA)1-1020161
MorningsideNewton, Massachusetts, United States (USA)11-5019868


Want to find more investors focusing on the veterinary vaccine manufacturers industry?

If you want to find more investors that are active in the veterinary vaccine manufacturersindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!